首页 | 本学科首页   官方微博 | 高级检索  
     

从“毒瘀交阻”理论辨治胃癌前病变的思路与方法
引用本文:惠建萍,沈舒文,刘 力,杜晓泉,王捷虹. 从“毒瘀交阻”理论辨治胃癌前病变的思路与方法[J]. 世界科学技术-中医药现代化, 2012, 14(1): 1270-1272
作者姓名:惠建萍  沈舒文  刘 力  杜晓泉  王捷虹
作者单位:陕西中医学院中医临床医学院 咸阳 712046;陕西中医学院附属医院脾胃病科 咸阳 712000;陕西中医学院中医临床医学院 咸阳 712046;陕西中医学院附属医院脾胃病科 咸阳 712001;陕西中医学院中医临床医学院 咸阳 712046;陕西中医学院附属医院脾胃病科 咸阳 712002;陕西中医学院中医临床医学院 咸阳 712046;陕西中医学院附属医院脾胃病科 咸阳 712003;陕西中医学院中医临床医学院 咸阳 712046;陕西中医学院附属医院脾胃病科 咸阳 712004
基金项目:国家自然科学基金(03873266):基于慢性萎缩性胃炎癌前病变虚实关联证候辨治的临床疗效评价方法研究,负责人:沈舒文;陕西省自然科学基础研究计划(2011JM4012):“解毒化瘀法”治疗毒瘀交阻型胃癌前病变临床效应分析,负责人:惠建萍;国家中医药管理局陕西中医学院附属医院脾胃病重点学科,学科带头人:沈舒文。
摘    要:胃癌是全球高发的恶性肿瘤之一,及早识别和控制胃癌前病变(PLGC)向胃癌发展是防治胃癌的重要途径。课题组在此前的研究中,认为毒瘀交阻是发生PLGC的主要病机,采用具有解毒化瘀作用的金果胃康胶囊治疗本病,取得了良好的疗效,故本文从"毒瘀交阻"理论探讨辨治胃癌前病变的思路与方法。

关 键 词:胃癌前病变  毒瘀交阻
收稿时间:2011-10-24
修稿时间:2012-02-10

Thought and Method of Syndrome Differentiation and Treatment Related to "Poison Stasis into Resistance" on Precancerous Lesion of Gastric Cancer
Hui Jianping,Shen Shuwen,Liu Li,Du Xiaoquan and Wang Jiehong. Thought and Method of Syndrome Differentiation and Treatment Related to "Poison Stasis into Resistance" on Precancerous Lesion of Gastric Cancer[J]. World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, 2012, 14(1): 1270-1272
Authors:Hui Jianping  Shen Shuwen  Liu Li  Du Xiaoquan  Wang Jiehong
Affiliation:Department of TCM, Shanxi University of Chinese Medicine, Xianyang 712046;Department of Spleen and Stomach Diseaes, Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712000, China;Department of TCM, Shanxi University of Chinese Medicine, Xianyang 712046;Department of Spleen and Stomach Diseaes, Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712001, China;Department of TCM, Shanxi University of Chinese Medicine, Xianyang 712046;Department of Spleen and Stomach Diseaes, Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712002, China;Department of TCM, Shanxi University of Chinese Medicine, Xianyang 712046;Department of Spleen and Stomach Diseaes, Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712003, China;Department of TCM, Shanxi University of Chinese Medicine, Xianyang 712046;Department of Spleen and Stomach Diseaes, Affiliated Hospital of Shanxi University of Chinese Medicine, Xianyang 712004, China
Abstract:Gastric cancer is one of malignant tumors with high disease incidence worldwide. Early detection and control the development from precancerous lesion of gastric cancer (PLGC) into gastric cancer is an important way to prevent and manage gastric cancer. In our previous research, the poison stasis into resistance was considered as the main pathogenesis of PLGC. Good curative effects have been achieved by the treatment with Jinguo-Weikang capsule for the purpose of detoxification and eliminating stasis. Therefore, the thought and method of syndrome differentiation and treatment by "poison stasis into resistance" theory on PLGC has been discussed.
Keywords:Precancerous lesion of gastric cancer   poison stasis into resistance
本文献已被 CNKI 等数据库收录!
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号